[
  {
    "ts": null,
    "headline": "JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease",
    "summary": "The FDA bestows a Fast Track designation to Johnson & Johnson's nipocalimab for treating moderate-to-severe Sjogren's disease in adults.",
    "url": "https://finnhub.io/api/news?id=9cc6acb2b3ec33fcc0839c941f79cd3a3b3ceba088689e228ee00160d8b5ad64",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742396340,
      "headline": "JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease",
      "id": 133324564,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The FDA bestows a Fast Track designation to Johnson & Johnson's nipocalimab for treating moderate-to-severe Sjogren's disease in adults.",
      "url": "https://finnhub.io/api/news?id=9cc6acb2b3ec33fcc0839c941f79cd3a3b3ceba088689e228ee00160d8b5ad64"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP",
    "summary": "Visa, Johnson & Johnson, Thermo Fisher and AMREP are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=1ab0daf53844f6f0a67296e9b9c1788ba682ec67414c337bc287214e177c05c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742374800,
      "headline": "The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP",
      "id": 133311385,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Visa, Johnson & Johnson, Thermo Fisher and AMREP are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=1ab0daf53844f6f0a67296e9b9c1788ba682ec67414c337bc287214e177c05c9"
    }
  }
]